Evidence map›Paper›PMID 28100279›Full record

ArticleBMC research notes2017

Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report.

Byung Woo Yoon, Yong Geon Song, Seung Hyeun Lee

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC research notes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Use of ribavirin in viruses other than hepatitis C. A review of the evidence.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2019
    Review
  14. [Use of ribavirin in viruses other than hepatitis C. A review of the evidence].Enfermedades infecciosas y microbiologia clinica · 2019
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Byung Woo YoonDepartment of Internal Medicine, Hanil General Hospital, Seoul, Republic of Korea.
Yong Geon SongDepartment of Internal Medicine, Hanil General Hospital, Seoul, Republic of Korea.
Seung Hyeun LeeDepartment of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea. humanmd04@hanmail.net.ORCID http://orcid.org/0000-0002-7666-313X
Hanil General Hospital · KRKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdenovirus is a common pathogen of acute upper respiratory infection in children and is generally self-limiting. Severe adenovirus infections have been reported in immunocompromised hosts especially bone marrow transplantation recipients due to hematologic malignancy. Severe adenovirus pneumonia in immunocompetent hosts has rarely been reported and optimal treatment has not been established. We report a case of community-acquired severe adenovirus pneumonia which was successfully treated with early administration of oral ribavirin. CASE PRESENTATION: A 39 year-old, previously healthy Korean male was admitted with symptoms of cough, myalgia, febrile sensation. Laboratory findings revealed that he had hypoxemia, thrombocytopenia and elevated transaminase. Chest imaging showed a consolidation with pleural effusion, which was rapidly progressed. All microbiological tests were negative except multiplex real-time reverse transcriptase polymerase chain reaction using respiratory specimen, which was positive for human adenovirus. Under the diagnosis of severe adenovirus pneumonia, we started oral ribavirin, which results in complete recovery without any complications.

conclusionsThis case demonstrates that oral ribavirin, instead of other expensive antiviral treatment, could be a good therapeutic option for the severe adenovirus pneumonia at least occurred in immunocompetent hosts.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanAdministration, OralAdultCommunity-Acquired InfectionsHumansImmunocompetenceImmunocompromised HostMalePneumonia, ViralRadiography, ThoracicReal-Time Polymerase Chain ReactionRibavirinRibavirinAdenovirusCase reportPneumoniaRibavirin

Identifiers

PMID28100279
PMCPMC5241922
OpenAlexW2572897808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.